BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 41 filers reported holding BRIDGEBIO PHARMA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,000,000 | -19.2% | 20,000,000 | -33.3% | 0.57% | -18.5% |
| Q2 2023 | $18,566,312 | -7.5% | 30,000,000 | -3.2% | 0.70% | +9.4% |
| Q1 2023 | $20,067,912 | +69.5% | 31,000,000 | 0.0% | 0.64% | +98.1% |
| Q4 2022 | $11,838,125 | -13.9% | 31,000,000 | 0.0% | 0.32% | -19.1% |
| Q3 2022 | $13,755,000 | +4.7% | 31,000,000 | 0.0% | 0.40% | -1.0% |
| Q2 2022 | $13,135,000 | -19.8% | 31,000,000 | -11.4% | 0.40% | -6.7% |
| Q1 2022 | $16,380,000 | – | 35,000,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 71,757,000 | $44,221,686 | 4.15% |
| Context Capital Management, LLC | 33,683 | $20,846 | 1.88% |
| INHERENT GROUP, LP | 9,000,000 | $5,587,173 | 1.54% |
| BRAIDWELL LP | 62,294,000 | $38,552,328 | 1.26% |
| Aequim Alternative Investments LP | 30,000,000 | $18,566,312 | 0.70% |
| DeepCurrents Investment Group LLC | 22,355,000 | $13,838,372 | 0.55% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 5,500,000 | $3,408,592 | 0.48% |
| ARISTEIA CAPITAL, L.L.C. | 30,280,000 | $18,739,598 | 0.42% |
| Weiss Asset Management LP | 4,500,000 | $2,773,209 | 0.21% |
| Orbimed Advisors | 15,000,000 | $9,265,350 | 0.17% |